|14.19||-0.51 / -3.47%|
Data as of 3:59pm ET
|14.58||+0.39 / +2.75%|
The 2 analysts offering 12-month price forecasts for Osiris Therapeutics Inc have a median target of 14.50, with a high estimate of 22.00 and a low estimate of 7.00. The median estimate represents a +2.18% increase from the last price of 14.19.
The current consensus among 2 polled investment analysts is to Buy stock in Osiris Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.